Physician profile
Kurt E Jacobson
NPI 1578502530
$594.37
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $134 · 2021: $145 · 2022: $94.38 · 2023: $47.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $47.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $47.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $161.56 | 2020-2022 | |
| Genentech USA, INC. | $150.00 | 2019 | |
| Stryker Corporation | $132.87 | 2021-2022 | |
| Polynovo North America LLC | $47.49 | 2023 | |
| Cgg Medical INC | $37.04 | 2021 | |
| Amgen INC. | $23.09 | 2019 | |
| Paragon 28, INC. | $18.60 | 2021 | |
| Next Science LLC | $11.95 | 2020 | |
| Smith+Nephew, INC. | $11.77 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Jacobson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.